Symposia: Allogeneic Transplantation: Disease Response and Comparative Treatment Studies
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, Biological therapies, Lymphoid Leukemias, ALL, clinical trials, adult, Translational Research, Clinical Practice (Health Services and Quality), Combination therapy, Clinical Research, health outcomes research, drug development, Diseases, patient-reported outcomes, Therapies, Immunotherapy, therapy sequence, real-world evidence, Lymphoid Malignancies, Myeloid Malignancies, Study Population, Human, Transplantation
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, Biological therapies, Lymphoid Leukemias, ALL, clinical trials, adult, Translational Research, Clinical Practice (Health Services and Quality), Combination therapy, Clinical Research, health outcomes research, drug development, Diseases, patient-reported outcomes, Therapies, Immunotherapy, therapy sequence, real-world evidence, Lymphoid Malignancies, Myeloid Malignancies, Study Population, Human, Transplantation
Monday, December 12, 2022: 2:45 PM-4:15 PM
391-392
(Ernest N. Morial Convention Center)
Moderators:
Ioanna Sakellari, Hematology Department - BMT Unit, G. Papanicolaou Hospital
and
Karen K. Ballen, MD, University of Virginia Health Center
Disclosures:
No relevant conflicts of interest to declare.
This oral session describes the clinical outcome after allogeneic transplantation in the setting of large prospective clinical trials. Major randomized trials will be presented, with high clinical relevance for treatment choice strategy in the context of allogeneic transplantation.
2:45 PM
3:00 PM
3:15 PM
3:30 PM
3:45 PM
4:00 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH